Skip to main content

887 publications

Name Date Type Actions

Monthy information regarding the total number of voting rights and shares making of the share capital - April 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Buyback programs - April 2024

Monthly communication regarding buyback programs

Liquidity contract

SALES 1st quarter 2024: €134M

The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products.

Public releases

Availability of the 2023 universal registration document

On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

Public releases

Universal registration document 2023 XBRL version

Universal Registration Document including the Annual Financial Report

Reference document

Universal registration document 2023

Universal Registration Document including the Annual Financial Report

Reference document

BALO : Notice of meeting

Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions

Shareholders´s Meeting

Monthly information regarding the total number of voting rights – March 2024

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Buyback programs - March 2024

Monthly communication regarding buyback programs

Description of buyback programs

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

Annual Report